COVID-19 has been one of the worst pandemics faced by humans since the Flu pandemic in 1918, which claimed the lives of 20-50 million individuals globally. The COVID-19 has brought about massive destruction of the global economy and an unprecedented loss of human life. To control the spread of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) worldwide, countries & governments have been adopting extensive testing strategies. The need for testing is more than ever now, as the COVID-19 to date has no therapeutic solution, including vaccines or drugs. The only possible way to curb the spread of the infection is to prevent further spread of the virus, and testing for COVID-19 cases is the need of the hour, asinfected cases of COVID-19 surge past 1.98 million.
The prominent players operating in the global COVID-19 diagnostics market are:
Seegene Inc., F. Hoffmann-La Roche Ltd, altona Diagnostics GmbH, SD BIOSENSOR, Abbott, BIOMEDOMICS INC., Bio-Rad Laboratories, Inc., VivaChek Biotech (Hangzhou) Co., Ltd., Sensing Self, PTE. Ltd, Thermo Fisher Scientific, PerkinElmer Inc., among others.
As the numbers of COVID-19 cases are surging across the globe, scientists have been mobilizing every resource to confront, delay, and stop its spread. The importance of diagnostic testing for COVID-19 is currently of colossal importance to help treat, isolate, or hospitalize infected people. Aggressive testing strategies are being adopted by governments around the globe to diminish the effect of this pandemic. For instance, South Korea, through its stringent diagnostic testing protocols, has managed to limit the spread of the virus, without following any aggressive lockdown strategies, unlike other countries such as India, Italy, U.S., the U.K., and others. Countries around the globe are adopting the South Korean model of mass testing for the virus to reduce the number of new cases and ultimately stop the spread of the virus.
Continuous research on SARS-CoV-2 have presented several data regarding the virus, including its impact on the global economy. However, to date controlling the spread of the virus to a grassroot level seems extremely difficult in the near future. However, on a national level, a country’s ability to test as many people as possible is keyto containing the outbreak and finding out the true fatality rate of the disease.
The COVID-19 Diagnostics Market is segmented on the basis of product type, Applications, Technology, and region
Major Test Types of COVID-19 Diagnostics Market covered are:
- Molecular Assays
- Serologic Immunoassays
- Ancillary Diagnostic Tests
Major Applications of COVID-19 Diagnostics Market covered are:
- Hospitals
- Public Health Labs
- Private or Commercial Labs
No comments:
Post a Comment